8-K
Current Report
Cellectar Biosciences, Inc. Filed Acc 0001144204-18-001202
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading tv482860_8k.htm…